In addition to anti‐nAChR antibodies, anti–muscle‐specific tyrosine kinase (MuSK) antibodies and anti–low‐density lipoprotein receptor‐related protein 4 (LRP4) antibodies have been identified in some patients with MG [135]. This evidence concerns the gene LRP4 and myasthenia gravis.